Amryt Pharma Plc (AMYT)

Trade AMYT now with
7/14/2022 7:27:11 AM Amryt Gets Orphan Drug Designation From FDA For Mycapssa For Treatment Of Carcinoid Syndrome
6/27/2022 7:18:34 AM Amryt Appoints Tracy Cunningham As Chief Medical Officer
6/24/2022 7:09:48 AM Amryt Plans To Submit Formal Dispute Resolution Request For Oleogel-S10 NDA
6/23/2022 7:27:45 AM Amryt Pharma: European Commission Approves Filsuvez For Dystrophic And Junctional EB
9/13/2021 7:13:50 AM Amryt Lifts FY Revenue Guidance To A Range Of $220 Mln - $225 Mln
6/2/2021 8:48:21 AM Amryt Says FDA Accepted For Filing Its NDA For Oleogel-S10
6/2/2021 8:38:14 AM Amryt Announces FDA Acceptance Of NDA For Oleogel-S10 For Epidermolysis Bullosa
5/5/2021 7:08:47 AM Amryt Signs Definitive Agreement To Acquire Chiasma In An All-stock Combination
3/29/2021 2:31:24 AM Amryt Announces Validation Of MAA For Oleogel-S10 By European Medicines Agency